What to watch with Pharmakogenetik Medicheck and Haut?

Combining pharmacogenetics (Medicheck) with skin analysis is an emerging area, but evidence remains limited. Pharmacogenetic tests can reveal variants in genes like CYP450 (e.g., CYP2D6, CYP3A4) that affect drug metabolism, including topical or systemic skin therapies (e.g., antibiotics, retinoids, corticosteroids). Some skin conditions such as acne, psoriasis, or eczema are treated with these agents, and genetic variants may influence efficacy or side effect risk. However, clinical implementation is not yet standard; most guidelines do not recommend routine genotyping before skin treatment. Additionally, skin tests (e.g., microbiome, barrier function) capture different factors not directly linked to pharmacogenetics. Caution: Do not self-medicate or adjust dosages based solely on DNA results. Evidence for specific skin-drug-gene interactions is mostly mechanistic or from small studies. A MyBody-X test may provide initial clues but does not replace professional medical advice.